Location History:
- Gwangju, KR (2023)
- Yongin-si, KR (2024)
Company Filing History:
2 out of 4 
1 out of 2,652 
1 out of 832,880 Years Active: 2023-2025
Title: Hyo Jin Kim: Innovator in Dual Modulation for Pain Therapy
Introduction
Hyo Jin Kim is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmacology, particularly in the development of dual modulators for therapeutic applications. With a total of 4 patents, his work focuses on innovative solutions for pain management.
Latest Patents
Hyo Jin Kim's latest patents include a dual modulator of mGluR5 and 5-HT2A receptor. This invention discloses a compound that acts as a modulator of mGluR5 while simultaneously serving as an antagonist of the 5-HT2A receptor. The therapeutic potential of this compound lies in its application as a pain relief agent, showcasing Kim's commitment to advancing medical treatments.
Career Highlights
Throughout his career, Hyo Jin Kim has worked with prominent companies such as Vivozon, Inc. and Hyundai Mobis Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Some of his notable coworkers include Dae Kyu Choi and Mi Seon Bae, who have contributed to his research and development efforts. Their collaboration has been instrumental in advancing the projects they have worked on together.
Conclusion
Hyo Jin Kim's innovative work in dual modulation represents a significant advancement in pain therapy. His contributions to the field are marked by his patents and collaborations, which continue to influence the landscape of pharmacological research.